The Centers for Medicare and Medicaid Services has just announced a $2.5 billion increase in funding for its investigation into Medicare drug prices.
The increase is part of the agency’s $100 billion budget request for fiscal year 2019, which is just about to expire.
The agency has spent a little over $2 billion investigating Medicare drug pricing over the past year.
This funding will be used to hire more investigators, including from the DEA, the U, the Justice Department and the Department of Health and Human Services.
It is not clear if any of the investigators will be able to investigate a particular case, or whether any cases will be assigned to a specific agency.
However, the agency is also seeking a few hundred thousand dollars for a new team of analysts, including more specialists, to be able examine drug prices more comprehensively and to identify drug pricing fraud.
The agency said in a statement on Friday that the funding would “support an ongoing, comprehensive, and comprehensive examination of the full scope of the problem.”